Calcium lactate 300mg tablets
Calcium lactate is a salt that consists of two lactate anions for each calcium cation (Ca2+).
Safety information for pregnancy and breastfeeding
Breastfeeding
Always consult your doctor or midwife before taking any medicine during pregnancy or while breastfeeding. Source: DrugBank (CC BY-NC 4.0).
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
View EudraVigilance report
Suspected adverse reactions reported for Calcium lactate
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
10 branded products available
WHO defined daily dose (DDD)
2 gram
Not a recommended dose. The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. It is a statistical measure used for research and comparison purposes only.
Source: WHO Collaborating Centre for Drug Statistics Methodology, distributed via the NHS dm+d supplementary BNF/ATC mapping files (NHSBSA). Contains public sector information licensed under the Open Government Licence v3.0.
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Guidelines from the National Institute for Health and Care Excellence
NICE clinical guidance(8)
Suspected sepsis in under 16s: recognition, diagnosis and early management (NG254)
i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department (MIB38)
Metastatic malignant disease of unknown primary origin in adults: diagnosis and management (CG104)
Mitochondrial disorders in children: Co-enzyme Q10 (ES11)
Preventing recurrent hypomagnesaemia: oral magnesium glycerophosphate (ESUOM4)
Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma (TA178)
Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management (NG240)
Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay) (HTG386)
Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 3 · Randomised trials: 1 · 1970–2026
Showing the 50 most relevant studies, sorted by most relevant.
Leora A. Shelef
Journal of Food Protection, 1994
Xiaolu Li, Yanyan Yang, Bei Zhang, et al.
Signal Transduction and Targeted Therapy, 2022
- Glycolysis
- Neoplasms
- Homeostasis
Jingjing Yang, Christopher A. Trickett, Salman B. Alahmadi, et al.
Journal of the American Chemical Society, 2017
- Metal-Organic Frameworks
- Lactates
- Models, Molecular
A. Catharine Ross, JoAnn E. Manson, Steven A. Abrams, et al.
The Journal of Clinical Endocrinology & Metabolism, 2010
- Calcium, Dietary
- Diet
- Nutrition Policy
Emanuel Manzurola, Alexander Apelblat
The Journal of Chemical Thermodynamics, 2002
Mark A. Thiede, Gideon A. Rodan
Science, 1988
- Gene Expression Regulation
- Adenylyl Cyclases
- Amino Acid Sequence
Irene Luna-Guzmán, D. Barrett
Postharvest Biology and Technology, 2000
A Prentice, LM Jarjou, Tim Cole, et al.
American Journal of Clinical Nutrition, 1995
- Calcium
- Calcium, Dietary
- Food, Fortified
Robert S. Goldie, Gregory J. King
American Journal of Orthodontics, 1984
- Lactation
- Tooth Movement Techniques
- Activator Appliances
Furlan IS, Carlos NR, Pinto AVD, et al.
2021
- Dentin Sensitivity
- Tooth Bleaching
- Tooth Bleaching Agents
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Pharmacology and chemical data from DrugBank
Key facts
Drug status
Approved
Major interactions
None known
Half-life
Not available
Mechanism
In aqueous environments such as the gastrointestinal (GI) tract, calcium lactate…
Food interactions
None known
Human targets
None mapped
Data: DrugBank · CC BY-NC 4.0
Pharmacokinetics at a glance
Absorption
25%
Half-life
Protein binding
Volume of distribution
99%
Metabolism
Elimination
20 to 30%
Clearance
Pharmacokinetic data: DrugBank · CC BY-NC 4.0
Known interactions with other medications. Always consult a healthcare professional.
Showing 50 of 162 interactions
How the body processes this drug — absorption, distribution, metabolism, and elimination
ATC A12AA05
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Show
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Linked compound data from DrugBank Open Data (CC BY-NC 4.0)
Calcium lactate
DrugBank citations
If you use DrugBank data in your research, please cite the following publications:
Show earlier publications
Structured knowledge from the free knowledge base
ATC classifications (Wikidata)
Linked open data from Wikidata (Q419693), a free and open knowledge base operated by the Wikimedia Foundation. Data is available under the Creative Commons CC0 1.0 Public Domain Dedication.